SEBOX
gene geneOn this page
Also known as OG9OG9X
Summary
SEBOX (SEBOX homeobox, HGNC:32942) is a protein-coding gene on chromosome 17q11.2, encoding Homeobox protein SEBOX (Q9HB31). Probable transcription factor involved in the control of specification of mesoderm and endoderm.
Homeodomain proteins, such as SEBOX, play a key role in coordinating gene expression during development (Cinquanta et al., 2000 [PubMed 10922053]).
Source: NCBI Gene 645832 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_001080837
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32942 |
| Approved symbol | SEBOX |
| Name | SEBOX homeobox |
| Location | 17q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OG9, OG9X |
| Ensembl gene | ENSG00000274529 |
| Ensembl biotype | protein_coding |
| OMIM | 610975 |
| Entrez | 645832 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000536498
RefSeq mRNA: 1 — MANE Select: NM_001080837
NM_001080837
CCDS: CCDS45634
Canonical transcript exons
ENST00000536498 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003625665 | 28364795 | 28364955 |
| ENSE00003716982 | 28365121 | 28365199 |
| ENSE00003789990 | 28363506 | 28364648 |
Expression profiles
Bgee: expression breadth broad, 37 present calls, max score 97.13.
Top tissues by expression
88 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 97.13 | gold quality |
| right lobe of liver | UBERON:0001114 | 55.53 | gold quality |
| liver | UBERON:0002107 | 48.15 | gold quality |
| bone marrow cell | CL:0002092 | 46.79 | gold quality |
| granulocyte | CL:0000094 | 46.63 | silver quality |
| colonic epithelium | UBERON:0000397 | 41.80 | gold quality |
| bone marrow | UBERON:0002371 | 39.89 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 39.09 | silver quality |
| blood | UBERON:0000178 | 39.05 | silver quality |
| adrenal tissue | UBERON:0018303 | 37.58 | silver quality |
| leukocyte | CL:0000738 | 37.38 | silver quality |
| monocyte | CL:0000576 | 37.35 | silver quality |
| muscle tissue | UBERON:0002385 | 36.72 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| sural nerve | UBERON:0015488 | 35.84 | gold quality |
| duodenum | UBERON:0002114 | 35.50 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| mucosa of stomach | UBERON:0001199 | 35.39 | gold quality |
| urinary bladder | UBERON:0001255 | 34.84 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 33.66 | silver quality |
| right adrenal gland | UBERON:0001233 | 33.48 | gold quality |
| adrenal gland | UBERON:0002369 | 32.95 | silver quality |
| prefrontal cortex | UBERON:0000451 | 32.57 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 32.56 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| right uterine tube | UBERON:0001302 | 31.94 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 30.92 | gold quality |
| lymph node | UBERON:0000029 | 30.82 | silver quality |
| frontal cortex | UBERON:0001870 | 30.48 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- This publication reported the human SEBOX gene sequence and predicted amino acid sequence, in addition to mouse and rat Sebox gene sequences. (PMID:10922053)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sebox | ENSDARG00000042526 |
| mus_musculus | Sebox | ENSMUSG00000001103 |
| rattus_norvegicus | Sebox | ENSRNOG00000009979 |
Paralogs (50): ARX (ENSG00000004848), PAX6 (ENSG00000007372), PAX7 (ENSG00000009709), ALX4 (ENSG00000052850), GSC2 (ENSG00000063515), PITX1 (ENSG00000069011), PAX2 (ENSG00000075891), RHOXF1 (ENSG00000101883), CRX (ENSG00000105392), EVX1 (ENSG00000106038), PAX4 (ENSG00000106331), NOBOX (ENSG00000106410), PITX3 (ENSG00000107859), PHOX2B (ENSG00000109132), OTX1 (ENSG00000115507), PRRX1 (ENSG00000116132), VSX2 (ENSG00000119614), ESX1 (ENSG00000123576), PAX8 (ENSG00000125618), PAX1 (ENSG00000125813), RHOXF2 (ENSG00000131721), GSC (ENSG00000133937), RAX (ENSG00000134438), PAX3 (ENSG00000135903), ALX3 (ENSG00000156150), HESX1 (ENSG00000163666), PITX2 (ENSG00000164093), UNCX (ENSG00000164853), PHOX2A (ENSG00000165462), OTX2 (ENSG00000165588), DRGX (ENSG00000165606), PRRX2 (ENSG00000167157), SHOX2 (ENSG00000168779), OTP (ENSG00000171540), RAX2 (ENSG00000173976), EVX2 (ENSG00000174279), PROP1 (ENSG00000175325), ISX (ENSG00000175329), ALX1 (ENSG00000180318), MIXL1 (ENSG00000185155)
Protein
Protein identifiers
Homeobox protein SEBOX — Q9HB31 (reviewed: Q9HB31)
Alternative names: Homeobox OG-9, Skin-, embryo-, brain- and oocyte-specific homeobox
All UniProt accessions (1): Q9HB31
UniProt curated annotations — full annotation on UniProt →
Function. Probable transcription factor involved in the control of specification of mesoderm and endoderm.
Subcellular location. Nucleus.
Similarity. Belongs to the paired homeobox family.
RefSeq proteins (1): NP_001074306* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR042223 | SEBOX | Family |
Pfam: PF00046
UniProt features (7 total): region of interest 2, compositionally biased region 2, chain 1, DNA-binding region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HB31-F1 | 66.86 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 38 (showing top):
GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_OOGENESIS, chr17q11, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_FEMALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_EMBRYO_DEVELOPMENT, LEIN_CEREBELLUM_MARKERS, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP, GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP, GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP, GSE20715_0H_VS_48H_OZONE_LUNG_DN, GOBP_SEXUAL_REPRODUCTION
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), embryo development ending in birth or egg hatching (GO:0009792), oogenesis (GO:0048477), cell differentiation (GO:0030154)
GO Molecular Function (2): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| embryo development | 1 |
| germ cell development | 1 |
| female gamete generation | 1 |
| cellular developmental process | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
530 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SEBOX | LBX1 | P52954 | 675 |
| SEBOX | TMEM200A | Q86VY9 | 476 |
| SEBOX | OOEP | A6NGQ2 | 459 |
| SEBOX | SCGN | O76038 | 452 |
| SEBOX | H1-8 | Q8IZA3 | 420 |
| SEBOX | NOBOX | O60393 | 418 |
| SEBOX | MYH8 | P13535 | 412 |
| SEBOX | CA8 | P35219 | 400 |
| SEBOX | TLE6 | Q9H808 | 389 |
| SEBOX | MYH13 | Q9UKX3 | 375 |
| SEBOX | KIF13B | Q9NQT8 | 374 |
| SEBOX | TARBP2 | Q15633 | 357 |
| SEBOX | VSTM2B | A6NLU5 | 357 |
| SEBOX | BNC1 | Q01954 | 352 |
| SEBOX | RHOXF2B | P0C7M4 | 348 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A5F9ZHS7, A1YGK1, A2T7E6, A8MZG2, O08574, O43593, O60393, O75593, O88621, O95231, P0C1T1, P0CG20, P20428, P97609, Q04667, Q17QR5, Q2KIS6, Q2M1V0, Q2T9Q7, Q32LE6, Q497V6, Q5JUK2, Q5M844, Q5RJB0, Q5TGS1, Q61645, Q61657, Q6ZMY3, Q6ZN32, Q6ZNG2, Q7RTU1, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8N1L9, Q8N7G0, Q8N944, Q8N9Y4
Diamond homologs: A1A546, A1YEV8, A1YG25, A2T711, A6NNA5, A6YP92, F1NEA7, G5EC89, L8E946, O14813, O35085, O35137, O35602, O35690, O42115, O42201, O42250, O42356, O42357, O42358, O42567, O43186, O54751, O70137, O73592, O75360, O95076, O97039, P06601, P09082, P09083, P0DMV5, P21711, P23759, P23760, P24610, P47239, P58304, P70368, P97458
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
414 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:28364952:CCGT:C | acceptor_gain | 0.9900 |
| 17:28364953:CGTC:C | acceptor_gain | 0.9900 |
| 17:28365106:C:A | donor_gain | 0.9900 |
| 17:28364953:CGT:C | acceptor_gain | 0.9800 |
| 17:28364956:C:CC | acceptor_gain | 0.9800 |
| 17:28364964:C:CT | acceptor_gain | 0.9700 |
| 17:28365105:T:TA | donor_gain | 0.9700 |
| 17:28364790:CTCA:C | donor_loss | 0.9600 |
| 17:28364791:TCACC:T | donor_loss | 0.9600 |
| 17:28364792:CACC:C | donor_loss | 0.9600 |
| 17:28364793:ACC:A | donor_loss | 0.9600 |
| 17:28364794:C:CG | donor_loss | 0.9600 |
| 17:28364793:A:T | donor_loss | 0.9300 |
| 17:28364794:C:A | donor_loss | 0.9300 |
| 17:28365115:GATCA:G | donor_loss | 0.9300 |
| 17:28365116:ATCAC:A | donor_loss | 0.9300 |
| 17:28365117:TCA:T | donor_loss | 0.9300 |
| 17:28365118:CACCT:C | donor_loss | 0.9300 |
| 17:28365119:A:G | donor_loss | 0.9300 |
| 17:28365120:CC:C | donor_loss | 0.9300 |
| 17:28365120:CCTG:C | donor_gain | 0.9200 |
| 17:28364954:GTCTG:G | acceptor_loss | 0.9100 |
| 17:28364955:TC:T | acceptor_loss | 0.9100 |
| 17:28364956:C:CA | acceptor_loss | 0.9100 |
| 17:28364957:T:A | acceptor_loss | 0.9100 |
| 17:28364955:TCTG:T | acceptor_loss | 0.9000 |
| 17:28364795:C:G | donor_loss | 0.8600 |
| 17:28364795:CT:C | donor_loss | 0.8600 |
| 17:28364647:AC:A | acceptor_loss | 0.8500 |
| 17:28364649:CT:C | acceptor_loss | 0.8500 |
AlphaMissense
1211 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:28364873:A:C | F38L | 0.866 |
| 17:28364873:A:T | F38L | 0.866 |
| 17:28364875:A:G | F38L | 0.866 |
| 17:28364909:G:C | F26L | 0.857 |
| 17:28364909:G:T | F26L | 0.857 |
| 17:28364911:A:G | F26L | 0.857 |
| 17:28364640:G:C | F67L | 0.829 |
| 17:28364640:G:T | F67L | 0.829 |
| 17:28364642:A:G | F67L | 0.829 |
| 17:28364906:G:C | S27R | 0.588 |
| 17:28364906:G:T | S27R | 0.588 |
| 17:28364908:T:G | S27R | 0.588 |
dbSNP variants (sampled 300 via entrez): RS1000063356 (17:28364109 G>C), RS1000664298 (17:28365300 G>A,T), RS1000732250 (17:28366554 C>G), RS1001202406 (17:28365581 C>T), RS1001896316 (17:28365968 C>A), RS1003918935 (17:28366020 G>T), RS1010302540 (17:28366580 G>C,T), RS1010616667 (17:28364047 G>A), RS1010856225 (17:28366930 C>T), RS1012744863 (17:28363179 T>C), RS1013459385 (17:28365635 G>A), RS1015276252 (17:28366217 G>A), RS1016227745 (17:28366022 G>A), RS1017281936 (17:28363714 C>T), RS1017861710 (17:28363553 G>A,C)
Disease associations
OMIM: gene MIM:610975 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002546_2 | Osteoprotegerin levels | 1.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| jinfukang | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.